Mounjaro dose in ml: what the volume in your pen actually means

Every Mounjaro KwikPen delivers 0.5 ml per dose, across all six UK strengths (2.5 mg through to 15 mg).
The pen is pre-filled and pre-set — you do not measure or draw up any volume yourself; the dose is dispensed automatically when the pen is activated.
Strength changes the concentration of tirzepatide in those 0.5 ml, not the liquid volume you receive.
Titration through the strengths is directed by your prescriber; no patient should adjust their dose or pen strength without clinical guidance.

Each dose of Mounjaro is delivered as a fixed subcutaneous injection of 0.5 ml, regardless of which strength you are using. Whether the pen contains 2.5 mg or 15 mg of tirzepatide, the liquid volume released per injection stays the same — only the concentration of the active medicine changes. Mounjaro is a prescription-only medicine and every dose is determined by a GPhC-registered prescriber following a full clinical assessment, not by the patient choosing a volume from a label.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The ml figure and what it tells you, and what it doesn't

You're holding a pen and wondering what's actually inside it

You've received your Mounjaro pen, it's sitting in the fridge, and somewhere on the packaging or in the patient leaflet you've spotted a volume figure. It's a reasonable thing to wonder about, especially if you've had experience with other injectable medicines where drawing up a syringe and measuring millilitres is part of the routine.

With Mounjaro, that routine doesn't exist. The KwikPen is self-contained and pre-loaded. Each single-dose pen holds exactly 0.5 ml of solution, and when you press the button, that 0.5 ml is delivered into the subcutaneous tissue at the abdomen, thigh, or upper arm. The pen then locks. There is no syringe, no vial, no measuring required on your part.

What changes between a 2.5 mg pen and, say, a 10 mg pen is not the volume but how much tirzepatide is dissolved into that 0.5 ml. The pharmaceutical term for this is concentration. Higher-strength pens contain a more concentrated solution; the liquid amount in the barrel stays fixed. This distinction matters because people sometimes interpret a 'higher dose' as meaning 'more fluid', which isn't the case here.

If you want to go deeper on what the volume looks like for a specific strength, the 5 mg pen's ml breakdown is a useful place to see how concentration and volume relate in practice.

Why the volume is fixed and the strength is not

Eli Lilly designed the KwikPen system so that the injection experience is consistent across the entire titration journey. You learn the technique once (same needle, same press, same 0.5 ml) and the only thing changing as your prescriber moves you up through the schedule is how potent those 0.5 ml are.

The UK licensed strengths run from 2.5 mg through 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg, as set out in the NHS tirzepatide guidance. Treatment typically begins at 2.5 mg, a strength chosen to give your system time to settle, not because it carries the same therapeutic load as the higher doses. Titration usually happens in roughly four-week steps, guided by your prescriber based on how you're tolerating treatment.

Each pen in the sequence releases the same 0.5 ml. So if you're comparing notes with someone on a different strength and they describe the injection as feeling 'the same', they're right about the mechanics. The biology is a different matter.

One practical note: the pen that arrives with DPD, in its plain unbranded box, already has the strength printed clearly on the cartridge label. If you're curious exactly how many ml are in a dose of Mounjaro, the answer is always 0.5 ml, and the pen will not dispense anything different.

What this means if you're mid-titration or transferring from another provider

A question our prescribers hear fairly regularly is whether a patient who has been on, say, 5 mg from one provider and wants to move to a higher strength needs to start from scratch. The ml figure itself doesn't change that picture, all pens deliver 0.5 ml regardless. What matters clinically is your current dose, how well you've tolerated it, and the evidence your new prescriber can review to confirm you've genuinely been on that strength.

At nume, transfer patients are asked to provide evidence of their current treatment before any dose increase is confirmed. A real clinician reads that information the same day, not a queue for automated processing. For context on how the cost side of treatment works across the different strengths, this page on Mounjaro pricing explains what's typically included in a private prescription fee.

If you'd like to understand the full picture of how each Mounjaro dose maps to ml across all strengths, that page covers the whole schedule in one place. And if you have specific questions about technique, storage, or what happens at your next dose increase, the nume FAQs are a useful first stop before reaching out to our team directly via the contact page.

What the volume figure cannot tell you

It's worth being clear about the limits of the ml number. Knowing that each pen delivers 0.5 ml tells you nothing about whether Mounjaro is clinically suitable for you, which strength is appropriate right now, or when your prescriber might consider moving you to the next step. Those decisions sit with the clinician, drawing on your weight, any weight-related conditions, how you've responded to the current dose, and your overall health picture.

For patients who want a concrete example of how concentration works in practice, the page explaining 5 mg Mounjaro in ml gives a clinician-facing view of dosing, contraindications and monitoring, useful reading if you want to understand the prescriber's framework. For patients, the patient information leaflet supplied with each pen remains the definitive reference for storage, missed doses, and injection technique. Both sources are consistent: the volume per injection is 0.5 ml, and adjusting it is not something a patient should attempt.

Mounjaro is a prescription-only treatment, the right starting point is a consultation with a clinician who can assess the full picture. Speak to our prescribers if you're unsure where you should be in the titration schedule or have questions before your next pen.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions